Journal Paper – Prof. Dr. Al-Masoudi https://al-masoudi.de Introducing Prof. Dr. Najim Al-Masoudi Fri, 14 Aug 2026 18:01:12 +0000 en-US hourly 1 212. Structure-aware graph transformers for repurposing steroid and 1,3,5-triazine chemotypes in prostate, pancreatic and colorectal carcinoma https://al-masoudi.de/pubs/212-structure-aware-graph-transformers-for-repurposing-steroid-and-135-triazine-chemotypes-in-prostate-pancreatic-and-colorectal-carcinoma/ Wed, 05 Aug 2026 16:12:58 +0000 https://al-masoudi.de/?post_type=publications&p=1421 211. New hybrid of pyrazole-conjugated chalcones. Synthesis, anticancer, antioxidant, and anti-AChE inhibitory activities, molecular docking, MD simulation and DFT study https://al-masoudi.de/pubs/211-new-hybrid-of-pyrazole-conjugated-chalcones-synthesis-anticancer-antioxidant-and-anti-ache-inhibitory-activities-molecular-docking-md-simulation-and-dft-study/ Wed, 05 Aug 2026 16:09:35 +0000 https://al-masoudi.de/?post_type=publications&p=1419 210. Synthesis of 1,3,5-triazine-indole conjugates as broad-spectrum coronavirus entry inhibitors https://al-masoudi.de/pubs/210-synthesis-of-135-triazine-indole-conjugates-as-broad-spectrum-coronavirus-entry-inhibitors/ Sat, 30 May 2026 15:48:33 +0000 https://al-masoudi.de/?post_type=publications&p=1415 209. Exploring of novel pyrazolidine-Schiff base hybrids derived from the drug loratadine as potential dual-acting agents: biological evaluation, in silico, MD simulations and TD-DFT studies https://al-masoudi.de/pubs/209-exploring-of-novel-pyrazolidine-schiff-base-hybrids-derived-from-the-drug-loratadine-as-potential-dual-acting-agents-biological-evaluation-in-silico-md-simulations-and-td-dft-studies/ Tue, 05 May 2026 09:46:00 +0000 https://al-masoudi.de/?post_type=publications&p=1406 208. Design and synthesis of novel benzothiazole–pyrazole–imine derivatives: evaluation of cytotoxicity against Panc-1 cells, antioxidant activity, and in silico properties https://al-masoudi.de/pubs/208-design-and-synthesis-of-novel-benzothiazole-pyrazole-imine-derivatives-evaluation-of-cytotoxicity-against-panc-1-cells-antioxidant-activity-and-in-silico-properties/ Tue, 05 May 2026 09:43:46 +0000 https://al-masoudi.de/?post_type=publications&p=1404 207. Integrated in silico evaluation of androstenediol derivative (monoxetanol) as a potential anticancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses https://al-masoudi.de/pubs/207-integrated-in-silico-evaluation-of-androstenediol-derivative-monoxetanol-as-a-potential-anticancer-agent-insights-from-molecular-docking-md-simulations-mm-pbsa-admet-and-dft-analyses/ Sat, 24 Jan 2026 21:18:57 +0000 https://al-masoudi.de/?post_type=publications&p=1399 206. Novel piperazin-pyrimidine hybrids as potential anticancer agents against MCF-7 breast carcinoma: synthesis, antimicrobial activity, antioxidant evaluation, and computational insights https://al-masoudi.de/pubs/novel-piperazin-pyrimidine-hybrids-as-anticancer-agents-in-mcf-7-breast-carcinoma-targeting-estrogen-receptor-alpha-er%ef%81%a1-and-egfr-with-synthetic-antioxidant-and-computational-insights/ Wed, 15 Oct 2025 14:08:50 +0000 https://al-masoudi.de/?post_type=publications&p=1378 204. Design, synthesis, and evaluation of novel 4,6-bis(substituted-phenoxy)-1,3,5-triazine analogues with selective activity against pancreatic (Capan-1) and colorectal (HCT-116) carcinomas: anticancer potential and DNA-binding affinity https://al-masoudi.de/pubs/204-design-synthesis-and-evaluation-of-novel-46-bissubstituted-phenoxy-135-triazine-analogues-with-selective-activity-against-pancreatic-capan-1-and-colorectal-hct-116-carcinomas-anticanc/ Sat, 19 Jul 2025 20:57:52 +0000 https://al-masoudi.de/?post_type=publications&p=1360 201. Design, synthesis, docking studies and molecular dynamics simulation of new 1,3,5-triazine derivatives as anticancer agents selectively targeting pancreatic adenocarcinoma (Capan-1) https://al-masoudi.de/pubs/201-design-synthesis-docking-studies-and-molecular-dynamics-simulation-of-new-135-triazine-derivatives-as-anticancer-agents-selectively-targeting-pancreatic-adenocarcinoma-capan-1/ Sun, 06 Jul 2025 20:45:11 +0000 https://al-masoudi.de/?post_type=publications&p=1342 203. N. A. Abdul-Ridha, A. M. Youssef, L. Elhafnaoui, Najim A. Al-Masoudi*, B. A. Saeed, W. A. Al-Masoudi, Novel beta-lactam derivatives of diclofenac and sulindac: Synthesis, anticancer, antioxidant activity, in silico studies and molecular dynamics simulation https://al-masoudi.de/pubs/203-n-a-abdul-ridha-a-youssef-n-a-al-masoudi-b-a-saeed-a-shtaiwi-novel-beta-lactam-derivatives-of-diclofenac-and-sulindac-synthesis-anticancer-antioxidant-activity-in-silico-studies/ Sat, 11 Jan 2025 20:51:01 +0000 https://al-masoudi.de/?post_type=publications&p=1334